On the move all over the world.
For surgeons and patients.
As an innovation leader, Medartis promotes technologies and solutions for osteosynthesis in the fields of cranio-maxillofacial surgery as well as upper and lower extremities. In close cooperation with international surgeons and scientists from leading clinics and universities. Developed and produced at the headquarters in Basel/Switzerland. For optimized treatment and an improved quality of life for patients. Worldwide.
million CHF net sales in 2017105
« BEING IN CLOSE CONTACT WITH OUR CUSTOMERS AND PARTNERS IS VERY IMPORTANT TO US. »
Chairman of the Strategy and Innovation Committee
Member of the Board of Directors
With the foundation of Medartis in 1997, Dr. h.c. Thomas Straumann laid the cornerstone for our current strong position in implants for cranio-maxillofacial surgery and the extremities. That was just the beginning. Because we're moving on. And making history in osteosynthesis.
Foundation of Institut Straumann AG by Prof. Dr. Reinhard Straumann. Specialisation in metallurgy for the watchmaking industry.
Merger of metallurgy and medicine by Dr. h.c. Fritz Straumann.
Sale of the Osteosynthesis Division to Stratec Medical (Straumann Technology, today Synthes J&J).
Spin-off of the dental division of Straumann AG by Dr. h.c. Thomas Straumann.
Foundation of Medartis AG with headquarters in Basel/Switzerland by Dr. h.c. Thomas Straumann. Acquisition of a small, independent specialist for oral and maxillofacial surgery and further development of the portfolio.
Start of the establishment of our own sales organisation and commencement of the development of the next generation of osteosynthesis technologies by experienced innovators.
Introduction of the TriLock® locking technology. Entry into the area of the upper extremities with hand and wrist systems.
Establishment of production at the new Bretzwil plant.
Awarded with the SME Entrepreneur Prize Northwestern Switzerland.
Medartis under one roof. Relocation of all parts of the company (administration, development, sales, production) to the new headquarters in the Stücki Business Park (Basel).
Entry into the fields of foot and elbow surgery.
Introduction of cannulated screws. Completion of the foot system (back foot).
Introduction of the arthrodesis system.
Introduction of the orthognathic system and completion of the elbow system.
Winner of the Prix SVC Northern Switzerland.
Introduction of a new generation of implants for the wrist.
Start of the focus on lower extremities with the introduction of new foot and ankle systems.
Willi Miesch receives the award “Ernst & Young Entrepreneur of the Year” in the Industry/High-tech/Life Sciences category.
Acquisition of the Mimedis company, active in pre-operative planning and 3D printing of patient-specific implants.
Initial public offering on the SIX Swiss Exchange.
The Executive Management Board of Medartis.
The Board of Directors of Medartis.